Clinical Trial Update: Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH [Phase 1, Phase 2]

View source ↗

Summary

A completed phase 1/2 clinical trial sponsored by Chuncheon Sacred Heart Hospital evaluated the effects of probiotic strains Pediococcus pentosaceus, Lactococcu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease
• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Lactobacillus helveticus (Lactobacillus helveticus)
• Lactococcus lactis (Lactococcus lactis)
• Pediococcus pentosaceus (Pediococcus pentosaceus)

Snippet

Sponsor: Chuncheon Sacred Heart Hospital | Conditions: Non-Alcoholic Fatty Liver Disease, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease | Phase 1, Phase 2 | Status: COMPLETED